Sigma Healthcare Ltd (ASX: SIG) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Sigma Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $31.05 billion
P/E Ratio 43.39
Dividend Yield 1.49%
Shares Outstanding 11.50 billion
Earnings per share 0.062
Dividend per share 0.04
Year To Date Return -7.14%
Earnings Yield 2.30%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Sigma Healthcare Ltd (ASX: SIG)
    Latest News

    Woman looking at a laptop and thinking.
    Broker Notes

    4 ASX shares scoring upgrades in the final week of earnings season

    Brokers have increased their ratings on Sigma Healthcare, Adairs, Netwealth, and other shares.

    Read more »

    Broker written in white with a man drawing a yellow underline.
    Broker Notes

    Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares

    The team at Morgans has given its verdict on these shares.

    Read more »

    Six smiling health workers pose for a selfie.
    Healthcare Shares

    Why now is the time to buy low on these ASX healthcare shares with up to 84% upside

    These two stocks have big upside.

    Read more »

    Mid-aged couple looking at a laptop.
    ASX Share Market News

    5 things to watch on the ASX 200 on Friday

    It could be a positive finish to the week for Aussie investors.

    Read more »

    Happy girl holding a plant and soil in front of ascending piles of coins.
    Investing Strategies

    Where I'd invest $10,000 in ASX shares in September

    These are four ASX shares I would happily buy this September.

    Read more »

    Female pharmacist smiles with a digital tablet.
    Earnings Results

    Sigma Healthcare FY26 earnings: Record profit as Chemist Warehouse merger delivers growth

    The company reported double-digit revenue growth.

    Read more »

    Woman using a pen on a digital stock market chart in an office.
    Investing Strategies

    My top 5 ASX 200 shares to buy and hold

    I like the long-term opportunities ahead of each of these businesses.

    Read more »

    Cheerful smiling businesswoman sitting on a chair and typing business report on a laptop keyboard.
    Retirement

    Why I'd buy Coles, Telstra and this ASX 200 blue chip share for retirement

    I would still want my money growing in retirement. These are three businesses I think could help me achieve that.

    Read more »

    A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
    ASX Share Market News

    ASX 200 technology and healthcare shares continued their comeback last week

    ASX 200 tech stocks rose 8.2% and healthcare increased 5.5% over the week.

    Read more »

    A woman presenting company news to investors looks back at the camera and smiles.
    Blue Chip Shares

    3 ASX 200 blue-chip shares I'd buy now

    Each of these companies owns something that would take a competitor years and considerable capital to recreate.

    Read more »

    Rising arrow on a blue graph symbolising a rising share price.
    Growth Shares

    2 ASX 200 shares I rate as top buys for growth

    I reckon these stocks offer significant potential.

    Read more »

    Woman serving customer in pharmacy.
    Healthcare Shares

    Chemist Warehouse: Are Sigma Healthcare shares a buy, hold, or sell?

    Bell Potter has been looking at the pharmacy giant following the release of a major report.

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    03 Sep 2026 $0.0200 100.00% Interim 22 Sep 2026
    04 Mar 2026 $0.0200 100.00% Final 20 Mar 2026
    02 Sep 2025 $0.0130 100.00% Interim 18 Sep 2025
    01 Oct 2024 $0.0050 0.00% Interim 17 Oct 2024
    28 Mar 2024 $0.0050 50.00% Final 17 Apr 2024
    25 Sep 2023 $0.0050 100.00% Interim 11 Oct 2023
    30 Mar 2023 $0.0050 100.00% Final 18 Apr 2023
    29 Sep 2022 $0.0050 100.00% Interim 12 Oct 2022
    04 Apr 2022 $0.0100 100.00% Final 22 Apr 2022
    24 Sep 2021 $0.0100 100.00% Interim 08 Oct 2021
    06 Apr 2021 $0.0100 100.00% Final 21 Apr 2021
    19 Sep 2019 $0.0100 100.00% Interim 04 Oct 2019
    03 Apr 2019 $0.0200 100.00% Final 29 Apr 2019
    12 Oct 2018 $0.0150 100.00% Interim 29 Oct 2018
    05 Apr 2018 $0.0250 100.00% Final 20 Apr 2018
    19 Sep 2017 $0.0250 100.00% Interim 05 Oct 2017
    06 Apr 2017 $0.0300 100.00% Final 21 Apr 2017
    20 Sep 2016 $0.0250 100.00% Interim 03 Oct 2016
    06 Apr 2016 $0.0300 100.00% Final 21 Apr 2016
    03 Apr 2014 $0.0200 100.00% Final 30 Apr 2014
    21 Sep 2012 $0.0200 100.00% Interim 26 Oct 2012
    05 Apr 2011 $0.1500 100.00% Special Cash 11 May 2011
    16 Oct 2009 $0.0300 100.00% Interim 13 Nov 2009
    31 Mar 2009 $0.0400 100.00% Final 07 May 2009
    30 Sep 2008 $0.0300 100.00% Interim 29 Oct 2008
    29 Aug 2005 $0.0200 100.00% Interim 15 Sep 2005
    02 Mar 2004 $0.2000 100.00% Final 23 Mar 2004

    SIG ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Sigma Healthcare Ltd

    Sigma Healthcare Ltd (ASX: SIG) is an Australian pharmaceutical wholesaler and retail pharmacy franchisor. Following its 2025 merger with Chemist Warehouse, Sigma now combines wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies with a large retail network operating under brands including Chemist Warehouse, Amcal, Discount Drug Stores, and My Chemist.

    The company also provides dose administration aid services and technology and data analytics solutions to its pharmacy customers. Sigma Healthcare was founded in 1912 and is headquartered in Clayton, Victoria.

    SIG Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    09 Oct 2026 $2.69 $0.07 2.67% 11,437,917 $2.63 $2.70 $2.62
    08 Oct 2026 $2.62 $-0.02 -0.76% 15,788,824 $2.64 $2.65 $2.59
    07 Oct 2026 $2.64 $0.02 0.76% 25,698,950 $2.63 $2.66 $2.63
    06 Oct 2026 $2.62 $0.02 0.77% 10,797,547 $2.62 $2.64 $2.60
    05 Oct 2026 $2.60 $0.00 0.00% 8,842,625 $2.60 $2.63 $2.59
    02 Oct 2026 $2.60 $0.03 1.17% 9,569,267 $2.58 $2.60 $2.57
    01 Oct 2026 $2.57 $-0.02 -0.77% 15,688,512 $2.58 $2.59 $2.55
    30 Sep 2026 $2.59 $0.03 1.17% 16,571,012 $2.56 $2.60 $2.55
    29 Sep 2026 $2.56 $0.00 0.00% 7,738,692 $2.56 $2.58 $2.54
    28 Sep 2026 $2.56 $-0.01 -0.39% 14,228,539 $2.55 $2.57 $2.55
    25 Sep 2026 $2.57 $-0.01 -0.39% 12,264,109 $2.58 $2.59 $2.56
    24 Sep 2026 $2.58 $0.02 0.78% 14,858,018 $2.53 $2.60 $2.53
    23 Sep 2026 $2.56 $0.00 0.00% 12,444,941 $2.57 $2.58 $2.55
    22 Sep 2026 $2.56 $0.03 1.19% 9,949,887 $2.51 $2.57 $2.51
    21 Sep 2026 $2.53 $-0.02 -0.78% 9,543,132 $2.54 $2.56 $2.52
    18 Sep 2026 $2.55 $0.05 2.00% 40,248,099 $2.50 $2.55 $2.47
    17 Sep 2026 $2.50 $-0.09 -3.47% 33,594,477 $2.59 $2.62 $2.50
    16 Sep 2026 $2.59 $-0.05 -1.89% 31,743,068 $2.64 $2.65 $2.59
    15 Sep 2026 $2.64 $0.01 0.38% 22,782,545 $2.63 $2.65 $2.62
    14 Sep 2026 $2.63 $0.00 0.00% 24,475,593 $2.62 $2.65 $2.61
    11 Sep 2026 $2.63 $-0.01 -0.38% 18,156,490 $2.63 $2.64 $2.62
    10 Sep 2026 $2.64 $-0.03 -1.12% 24,863,126 $2.65 $2.66 $2.64

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    18 Sep 2026 Mario Verrocchi Buy 2,000,000 $5,092,146
    On-market trade.
    14 Sep 2026 Neville Mitchell Buy 20,000 $53,100
    On-market trade.
    31 Aug 2026 Vikesh Ramsunder Issued 564,896 $1,519,570
    Issue of securities. 2,389,068 rights and performance shares
    09 Jan 2026 Vikesh Ramsunder Issued 813,449 $2,350,867
    Issue of securities. 1824172 Rights
    09 Jan 2026 Danielle Di Pilla Issued 141,591 $409,197
    Issue of securities. 141,591 2025 LTI Rights
    09 Jan 2026 Mario Verrocchi Issued 314,021 $907,520
    Issue of securities. 314,021 2025 LTI Rights
    10 Nov 2025 Annette Carey Buy 10,000 $31,237
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Christopher Graham Roberts Non-Executive Director Oct 2023
    Dr Roberts is the Chair of the Risk, Compliance and Sustainability Committee. He has more than 40 years' experience in the medical device industry, including as the Executive Vice President of ResMed Inc (NYSE:RMD) from 1992 to 2003 and as a director of ResMed Inc until November 2017. Dr Roberts is currently a Non-Executive Director of Nutromics Pty Ltd, Atmo Biosciences Limited and the Cochlear Foundation Board. Dr Roberts is also a Governor of the Centenary Institute Cancer Medicine and Cell Biology.
    Mr Neville Mitchell Non-Executive Director Feb 2023
    Mr Mitchell is member of the IBC Committee. Mr Mitchell has financial experience coupled with board experience as a Non-Executive Director. He is currently a Non-Executive Director of Sonic Healthcare Limited from September 2017. He is Chair of the Sonic Audit Committee. He has international healthcare and finance experience. Prior to becoming a Non-Executive Director, he had a career spanning 27 years with Cochlear Limited and 22 years as Chief Financial Officer and Company Secretary.
    Mr Michael Sammells Non-Executive DirectorNon-Executive Chairman Feb 2020
    Mr Sammells is also the Chair of the Related Party Independent Board Committee (IBC). He is currently a Non-Executive Director at AMP Limited and a director at GMHBA. He has over 35 years of experience in finance, corporate services and has held operational roles with experience in finance, accounting, treasury, investor relations, capital developments, mergers and acquisitions and IPOs. He is a former Chief Financial Officer of Healthscope Limited and Medibank Private.
    Mr Vikesh Ramsunder Chief Executive OfficerManaging Director Feb 2022
    Mr Ramsunder brings blend of operational leadership, strategic focus, industry and financial acumen. He has experience in wholesaling, logistics, pharmacy and retailing, and was integral to the growth of the Clicks Group which is now one of the pharmacy and retail operations in Africa. Prior to joining Sigma, Mr Ramsunder spent 28 years with the Clicks Group, including 18 years as a member of the executive team. Mr Ramsunder served as Group CEO from January 2019 to December 2021 and previously held senior leadership positions including Chief Operating Officer from 2015 and Managing Director of the pharmaceutical wholesaler business, United Pharmaceutical Distributors from 2010.
    Ms Annette May Carey Non-Executive Director Apr 2023
    Ms Carey is member of the IBC and Member of the Risk, Compliance and Sustainability Committee. She is a current Non-Executive Director of Downer EDI Limited, Bapcor Limited and the Kinetic bus group. She was a previous Non-Executive Director of National Intermodal Corporation. She previously held legal roles at two commercial law firms and the Lendlease group before joining Linfox Logistics and progressing from General Counsel and Company Secretary to Chief Executive Officer of Linfox Logistics ANZ and Linfox Armaguard. She also held the position of Executive General Manager International with Australia Post. She has held director roles within the Linfox group of companies and been Chair or Deputy Chair of Australia Post joint ventures in the UK and China. She has a balance of technical experience as well as legal, strategic and commercial intellect from over 30 years' experience in supply chain, logistics, cross border e-commerce and commercial law.
    Mr Jack Gance Non-Executive Director Feb 2025
    Mr Gance is member of the Risk, Compliance and Sustainability Committee. He co-founded Chemist Warehouse with Mr S Gance. He was previously Chair of Chemist Warehouse. He opened his first pharmacy store in Reservoir, Victoria, with Mr S Gance in 1972. In 1997, Messrs Gance and Mr Verrocchi, established MyChemist and opened the first MyChemist store. In 2000, they established the Chemist Warehouse chain and opened the first Chemist Warehouse store. Mr Gance also created the brands Le Specs, Le Tan and Colours of Australis.
    Ms Danielle Di Pilla Executive Director Feb 2025
    Ms Di Pilla is a Member of the Risk, Compliance and Sustainability Committee. She established DPP Pharmaceuticals Pty Ltd (DPP) in 2000 and is the founder of brands such as Goat Soap, which has had international success. Ms Di Pilla is the Managing Director of DPP since it was incorporated. She also currently sits on the Board of Gotcha4Life.
    Mr Mario Verrocchi Executive Director Feb 2025
    Mr Verrocchi is a Member of the Risk, Compliance and Sustainability Committee. He is also the Chief Executive Officer - Retail. He joined Mr J Gance and Mr S Gance's pharmacy group in 1982. He established MyChemist with Messrs Gance in 1997 and subsequently created the Chemist Warehouse chain with Messrs Gance in 2000.
    Mr Damien Gance Executive Director Feb 2025
    Mr Gance is a Member of the Risk, Compliance and Sustainability Committee. He joined MyChemist in 1998 and was the first Chemist Warehouse Franchisee opening the first Chemist Warehouse pharmacy in June 2000. He was previously the Chief Strategy and Business Development Officer of the Group.
    Ms Kara McGowan General Counsel Chief Legal OfficerCompany Secretary Oct 2021
    -
    Kara McGowan General Counsel Chief Legal OfficerCompany Secretary
    -
    Richard Murray CFO
    -
    Gary Woodford Other Executive Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Mfv Family Foundation Pty Ltd 2,233,512,925 19.35%
    HSBC Custody Nominees (Australia) Limited 1,568,948,429 13.59%
    Jeg Family Foundation Pty Ltd 1,395,930,781 12.09%
    Sg Family Foundation Pty Ltd 1,301,217,384 11.27%
    Citicorp Nominees Pty Limited 1,124,032,765 9.74%
    J P Morgan Nominees Australia Pty Limited 726,155,579 6.29%
    Mjv Family Foundation Pty Ltd 280,000,000 2.43%
    Av Family Foundation Pty Ltd 275,524,439 2.39%
    BNP Paribas Noms Pty Ltd 156,027,444 1.35%
    Mr Sunil Narula 155,893,114 1.35%
    Dgsr Family Foundation Pty Ltd 127,329,615 1.10%
    BNP Paribas Nominees Pty Ltd 92,318,155 0.80%
    Rispin Mott Nominees Pty Ltd 67,615,674 0.59%
    NMS Nominees Pty Ltd 65,065,709 0.56%
    NMS Nominees Pty Ltd i 55,986,218 0.48%
    Citicorp Nominees Pty Limited i 53,100,179 0.46%
    Mat Family Foundation Pty Ltd 48,144,781 0.42%
    Invia Custodian Pty Limited 47,500,000 0.41%
    UBS Nominees Pty Ltd 47,229,447 0.41%
    Netwealth Investments Limited 42,696,069 0.37%

    Profile

    since

    Note